LEF1与AR在胰腺实性假乳头状肿瘤细胞学诊断中的价值
该研究在19例SPN细胞学标本及15例对应手术切除标本中评估LEF1和AR的免疫组化表现,并以23例非SPN肿瘤作为对照。LEF1在细胞学中敏感度94.7%、特异度87%,AR特异度100%但敏感度仅25%,提示LEF1对细胞学诊断SPN有价值而AR价值有限。
要点
- LEF1在SPN细胞学标本中敏感度94.7%、特异度87%,可作为细胞块免疫标记。
- AR在SPN细胞学中特异度100%但敏感度仅25%,单独使用诊断价值有限。
- LEF1在对应手术切除标本中15/15阳性,支持其作为SPN标记物。
核心结论
- LEF1在SPN细胞学材料中敏感度94.7%、特异度87%,可能是有价值的免疫标记。
- AR特异度100%但敏感度25%,在细胞学诊断SPN中价值可能有限。
研究设计与样本
- 对来自2个机构的19例SPN细胞学病例和15例对应手术切除标本进行LEF1和AR免疫组化。
- 以23例非SPN肿瘤细胞学及对应手术标本评估特异性,包括4例腺泡细胞癌、9例胰腺神经内分泌肿瘤和10例导管腺癌。
- 阳性定义为肿瘤细胞核内任何核染色。
主要发现
- LEF1在18/19例细胞学病例(94.7%)和15/15例手术切除标本(100%)中阳性。
- AR在4/16例细胞学病例(25.0%)和4/15例手术切除标本(26.7%)中阳性。
- 在非SPN肿瘤中,LEF1特异度为87%,AR特异度为100%。
关键数值与推荐
- LEF1在SPN细胞学中敏感度94.7%、特异度87%。
- AR在SPN细胞学中特异度100%、敏感度25%。
- LEF1和AR阳性均定义为肿瘤细胞核内任何核染色。
临床怎么用
- LEF1免疫染色可用于细胞块材料辅助诊断SPN。
- AR因敏感度低,在细胞学中单独诊断SPN的价值有限。
局限性
- 细胞学病例数较少(19例SPN,AR仅16例可评估)。
- 研究来自2个机构,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Solid pseudopapillary neoplasm (SPN) is an uncommon tumor that is challenging to diagnose on cytology due to morphologic overlap with other pancreatic neoplasms. Recently, putative diagnostic markers for SPN have been reported in the surgical pathology literature, with nuclear positivity for lymphoid enhancer-binding factor 1 (LEF1) and androgen receptor (AR) identified in >90% and >80% of cases, respectively. In the current study, the authors sought to evaluate the sensitivity and specificity of LEF1 and AR on SPN cytology specimens and available corresponding surgical resection specimens. METHODS: Immunohistochemistry was performed using monoclonal antibodies against LEF1 and AR on 19 SPN cytology cases and 15 corresponding follow-up surgical resection specimens from 2 institutions. To evaluate specificity, the authors stained 23 non-SPN tumors diagnosed on cytology with corresponding surgical specimens (4 acinar cell carcinomas, 9 pancreatic neuroendocrine tumors, and 10 ductal adenocarcinomas). Positivity for LEF1 and AR was defined as any nuclear staining within neoplastic nuclei. RESULTS: LEF1 was found to be positive in 18 of 19 cytology cases (94.7%) and 15 of 15 corresponding surgical resection specimens (100%). AR was positive in 4 of 16 cytology cases (25.0%) and 4 of 15 corresponding surgical resection specimens (26.7%). Among non-SPN tumors, LEF1 demonstrated a specificity of 87% whereas the specificity for AR was 100%. CONCLUSIONS: LEF1 for SPN on cytology material was found to demonstrate a sensitivity of 94.7% and a specificity of 87%. Although AR was found to have a specificity of 100%, its sensitivity was lower (25%). LEF1 could be a valuable immunostain on cytology cell block material for the diagnosis of SPN. However, the same may not hold true for AR.
引用
- McHugh KE, Stelow EB, Harrison GP, et al. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology. Cancer Cytopathol. 2019. PMID: 31584754. doi:10.1002/cncy.22186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。